NCT00533637 - Taste and Local Tolerance Study of NLA Nasal Spray in Patients With Allergic Rhinitis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2007

Study Completion Date

December 31, 2007

Conditions

Allergic Rhinitis

Interventions

DRUG

Cetirizine dihydrochloride (10 mg/ml) liposomal formulation

2x110μL in each nostril twice daily for 7 days

DRUG

Cetirizine dihydrochloride (10 mg/ml) buffer solution

2x110μL in each nostril, as a single dose

DRUG

Placebo

Citrate buffer with preservatives

Trial Locations (1)

Department of Otorhinolaryngology, Lund University Hospital, Lund